Supercharged immune cells take on Drug-Resistant infections

This trial investigates whether specially grown immune cells, called pathogen-specific cytotoxic T lymphocytes (CTLs), can safely and effectively treat stubborn infections like EBV, CMV, and adenovirus in people with weakened immune systems, such as stem cell or organ transplant recipients. Participants receive one or more infusions of these cells, which are designed to target and kill infected cells. The study aims to see if this approach can reduce viral levels and control infections when standard drugs have failed or cannot be used.